A study of epirubicin, cisplatin and prolonged infusional 5-FU (ECF) treatment for relapsed epithelial ovarian cancer

被引：0
|
作者：
Blagden, SP [1 ]
Earl, HM [1 ]
Brenton, J [1 ]
Murray, N [1 ]
Shaw, CJ [1 ]
机构：
[1] Addenbrookes Hosp, Dept Med Oncol, Cambridge CB2 2QQ, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P316
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] EPIRUBICIN, CISPLATIN AND INFUSIONAL 5-FLUOROURACIL (5-FU) (ECF) IN HEPATOBILIARY TUMORS
    ELLIS, PA
    NORMAN, A
    HILL, A
    OBRIEN, MER
    NICHOLSON, M
    HICKISH, T
    CUNNINGHAM, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1594 - 1598
  • [2] Perioperative chemotherapy with epirubicin, cisplatin, and 5-FU (ECF) for gastroesophageal cancer: A retrospective analysis
    Bichev, D.
    Breithaupt, K.
    Dogan, Y.
    Grieser, C.
    Pfiffer, T. E.
    Daum, S.
    Treese, C.
    Schumacher, G.
    Doerken, B.
    Thuss-Patience, P. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
    Sadighi, Sanambar
    Mohagheghi, Mohammad Ali
    Montazeri, Ali
    Sadighi, Zahra
    [J]. BMC CANCER, 2006, 6 (1)
  • [4] Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
    Sanambar Sadighi
    Mohammad Ali Mohagheghi
    Ali Montazeri
    Zahra Sadighi
    [J]. BMC Cancer, 6
  • [5] Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma
    Lee, MA
    Woo, IS
    Kang, JH
    Hong, YS
    Lee, KS
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (06) : 346 - 350
  • [6] Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma
    Myung Ah Lee
    In Sook Woo
    Jin-Hyoung Kang
    Young Seon Hong
    Kyung Shik Lee
    [J]. Journal of Cancer Research and Clinical Oncology, 2004, 130 : 346 - 350
  • [7] Epirubicin, cisplatin and continuous 5-FU chemotherapy (ECF-regimen) in patients with cancer of the gastroesophageal junction and stomach
    Boot, H
    Cats, A
    Tonino, S
    Zuetenhorst, H
    Kuijer, P
    Swart, M
    Taal, B
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A601 - A601
  • [8] Docetaxel and 5-FU continuous infusion (DF) versus epirubicin, cisplatin and 5-FU (ECF) for advanced gastric adenocarcinoma:: A randomised phase II study.
    Thuss-Patience, PC
    Kretzschmar, A
    Vielhaber, A
    Dörken, B
    Reichardt, P
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [9] Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-FU (ECF) before and after 3D-conformal radiotherapy with continuous infusional 5-FU: A multicentre study of the trans-tasman radiation oncology group (FROG)
    Leong, T.
    Michael, M.
    Lim Joon, D.
    Willis, D.
    Jayamoham, J.
    Spry, N.
    Harvey, J.
    Di Hulio, J.
    Milner, A.
    Mann, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S107 - S107
  • [10] A phase II study of epirubicin, carboplatin and infusional 5-FU in hormone resistant prostate cancer.
    Newby, JC
    Leonard, P
    Fenwick, E
    Harland, SJ
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 : 68 - 68
12345